Improvement of the Prognosis Assessment of Severe Tricuspid Regurgitation by the Use of a Five-Grade Classification of Severity

• Published in: The American journal of cardiology Vol. 132; pp. 119 - 125
• Main Authors: Peugnet, Fanny, Bohbot, Yohann, Chadha, Gagandeep, Delpierre, Quentin, Kubala, Maciej, Delabre, Justine, Landemaine, Thomas, Beyls, Christophe, Tribouilloy, Christophe
• Format: Journal Article
• Language: English
• Published: New York Elsevier Inc 01.10.2020; Elsevier Limited; Elsevier
• Subjects: Body mass index; Cardiovascular disease; Cardiovascular diseases; Classification; Comorbidity; Confidence intervals; Congestive heart failure; Coronary vessels; Diuretics; Etiology; Gender; Health hazards; Heart; Hepatic vein; Laminar flow; Life Sciences; Medical prognosis; Patients; Prognosis; Quality; Regurgitation; Rheumatic heart disease; Surgery; Survival; Tricuspid valve; Ventricle
• ISSN: 0002-9149; 1879-1913
• DOI: 10.1016/j.amjcard.2020.06.044

It is well known that some patients present with “more than severe” tricuspid regurgitation (TR). We aimed to assess the prognosis of these very severe TR patients. We defined very severe TR using 3 simple echocardiographic parameters: a coaptation gap≥10mm, a laminar TR flow and a systolic reversal of the hepatic vein flow. We included 259 consecutive patients (76 ± 13 years; 46% men) with moderate-to-severe TR (n = 114) and severe TR (n = 145). The primary end point was the combination of hospitalisation for right heart failure (RHF) and cardiovascular mortality. Median follow-up was 24(7 to 47) months. In patients with severe TR, 52 (36%) met the definition of very severe TR. These patients were younger, had more history of RHF and were more frequently treated with loop diuretics than those with moderate-to-severe TR (all p < 0.001). Four-year event-free survival rates were 68 ± 5%, for moderate-to-severe TR, 48 ± 6% for severe TR and only 35 ± 7% for very-severe TR (p < 0.001). On multivariable analysis, after adjustment for outcome predictors including age, comorbidity, RHF, TR etiology, left and right ventricular dysfunction, and tricuspid valve surgery, patients with very severe TR had a worsened prognosis than those with moderate-to-severe TR (Adjusted Hazard Ratio [95% Confidence Interval] = 2.43 [1.18 to 5.53]; p = 0.002) and than those with severe TR (Adjusted Hazard Ratio [95% Confidence Interval] = 2.23 [1.06 to 5.56]; p = 0.015). In conclusion, very severe TR is frequent in patients with severe TR, corresponds to a more advanced stage of the disease and is associated with poor outcomes. Therefore, the use of a 5-grade classification of TR severity is justified in routine clinical practice. (ID-RCB: 2017-A03233-50).